2.2. Participants
chronic kidney disease
UNCONTROLLED HYPERTENSION, LIVER DISEASE, ISCHEMIC STROKE, BILIARY DISEASE, SECONDARY, ACUTE CORONARY SYNDROME, TYPE 2 DIABETES, DYSLIPIDEMIA
Patients were eligible for enrollment if they had LDL cholesterol fasting serum levels ≤ 250 mg/dL and triglyceride levels < 400 mg/dL at Visit 1 and had appropriate ranges of LDL cholesterol levels according to the defined risk category at Visit 2. Patients who had the following conditions were excluded: a history of acute coronary syndrome, ischemic stroke, percutaneous coronary intervention or coronary bypass graft surgery within the last 6 months; uncontrolled type 2 diabetes (fasting glucose > 160 mg/dL or HbA1c > 9%); uncontrolled hypertension; secondary dyslipidemia; comorbidities such as active liver disease, biliary disease, chronic kidney disease (estimated glomerular filtration rate < 30 mL/min/1.73 m